A Rational Approach for Improving the Ascorbate Antineoplastic Activity

REFERENCES

• Stephenson CM, Levin RD, Spector T, Lis CG. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol 2013;72:139–146.
   PubMed Web of Science ®Google Scholar
• Parrow NL, Leshin JA, Levine M. Parenteral ascorbate as a cancer therapeutic: A reassessment based on pharmacokinetics. Antioxid Redox Signal 2013;19:2141–2156.
   PubMed Web of Science ®Google Scholar
• Welsh JL, Wagner BA, van't Erve TJ, Zehr PS, Berg DJ, Halfdanarson TR, Yee NS, Bodeker KL, Du J, Roberts LJ 2nd, Drisko J, Levine M, Buettner GR, Cullen JJ. Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): Results from a phase I clinical trial. Cancer Chemother Pharmacol 2013;71:765–775.
   PubMed Web of Science ®Google Scholar
• Kovago C, Meggyeshazi N, Andocs G, Szasz A. Report of the pilot study done for the proposed investigation on the possible synergic effect between high-dose ascorbic acid application and oncothermia treatment. Conf Papers Med, vol. 2013, Article ID 386913, 2 pp. doi:10.1155/2013/386913
   Google Scholar
• Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 1976;73: 3685–3689.
   PubMed Web of Science ®Google Scholar
• Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979;301:687–690.
   PubMed Web of Science ®Google Scholar
• Levine M, Padayatty SJ, Espey MG. Vitamin C: A concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr 2011;2:78–88.
   PubMed Web of Science ®Google Scholar
• Chen Q. Vitamin C in cancer treatment: Where pharmacokinetics speaks. J Drug Metab Toxicol 2012;3:e107.
   Google Scholar
• Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 2005;102:13604–13609.
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR, Levine M. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 2007;104:8749–8754.
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA 2008;105: 11105–11109.
   PubMed Web of Science ®Google Scholar
• Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, Rousseau C, Robitaille L, Miller WH Jr. Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol 2008;19:1969–1974.
   PubMed Web of Science ®Google Scholar
• Levine M, Espey MG, Chen Q. Losing and finding a way at C: New promise for pharmacologic ascorbate in cancer treatment. Free Radic Biol Med 2009;47:27–29.
   PubMed Web of Science ®Google Scholar
• Verrax J, Calderon PB. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic Biol Med 2009;47:32–40.
   PubMed Web of Science ®Google Scholar
• Davies KJ. The broad spectrum of responses to oxidants in proliferating cells: A new paradigm for oxidative stress. IUBMB Life 1999;48:41–47.
   PubMed Web of Science ®Google Scholar
• Symons MC, Rusakiewicz S, Rees RC, Ahmad SI. Hydrogen peroxide: A potent cytotoxic agent effective in causing cellular damage and used in the possible treatment for certain tumours. Med Hypotheses 2001;57:56–58.
   PubMed Web of Science ®Google Scholar
• Finkel T. Signal transduction by reactive oxygen species. J Cell Biol 2011;194:7–15.
   PubMed Web of Science ®Google Scholar
• Du J, Cullen JJ, Buettner GR. Ascorbic acid: Chemistry, biology and the treatment of cancer. Biochim Biophys Acta 2012;1826:443–457.
   PubMed Web of Science ®Google Scholar
• Carosio R, Zuccari G, Orienti I, Mangraviti S, Montaldo PG. Sodium ascorbate induces apoptosis in neuroblastoma cell lines by interfering with iron uptake. Mol Cancer 2007;6:55. doi:10.1186/1476-4598-6-55.
   PubMedGoogle Scholar
• Antunes F, Cadenas E. Cellular titration of apoptosis with steady state concentrations of H2O2: Submicromolar levels of H2O2 induce apoptosis through Fenton chemistry independent of the cellular thiol state. Free Radic Biol Med 2001;30:1008–1018.
   PubMed Web of Science ®Google Scholar
• Manning J, Mitchell B, Appadurai DA, Shakya A, Pierce LJ, Wang H, Nganga V, Swanson PC, May JM, Tantin D, Spangrude GJ. Vitamin C promotes maturation of T-cells. Antioxid Redox Signal 2013;19:2054–2067.
   PubMed Web of Science ®Google Scholar
• Duarte TL, Almeida GM, Jones GD. Investigation of the role of extracellular H2O2 and transition metal ions in the genotoxic action of ascorbic acid in cell culture models. Toxicol Lett 2007;170:57–65.
   PubMed Web of Science ®Google Scholar
• Bocci V In Interferon, In vivo and clinical studies, vol. 4, NB Finter, R Oldham (eds.). (Amsterdam: Elsevier), 1985, 47–72.
   Google Scholar
• Bocci V. Immunomodulators as local hormones: New insights regarding their clinical utilization. J Biol Response Mod 1985;4:340–352.
   PubMedGoogle Scholar
• Bocci V. In Interferon. Principles and medical application, S Baron, DH Coppenhaver, F Dianzani, WR Fleischmann, TK Hughes, GR Klimpel, DW Niesel, GJ Stanton, SK Tyring (eds.). UTMB Press: Galveston, TX, USA, 1992:417–425.
   Google Scholar
• Pru C, Eaton J, Kjellstrand C. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Nephron 1985;39:112–116.
   PubMed Web of Science ®Google Scholar
• Alkhunaizi AM, Chan L. Secondary oxalosis: A cause of delayed recovery of renal function in the setting of acute renal failure. J Am Soc Nephrol 1996;7:2320–2326.
   PubMed Web of Science ®Google Scholar
• Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M. Vitamin C: Intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 2010;5:e11414.
   PubMed Web of Science ®Google Scholar
• Bocci V, Zanardi I, Pérez Olmedo JC, Travagli V. A technically feasible treatment for peritoneal carcinomatosis. Int J Ozone Ther 2012;11:85–89.
   Google Scholar
• González MJ, Miranda-Massari JR, Mora EM, Guzmán A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Román-Franco A. Orthomolecular oncology review: Ascorbic acid and cancer 25 years later. Integr Cancer Ther 2005;4:32–44.
   PubMedGoogle Scholar
• Duconge J, Miranda-Massari JR, Gonzalez MJ, Jackson JA, Warnock W, Riordan NH. Pharmacokinetics of vitamin C: Insights into the oral and intravenous administration of ascorbate. P R Health Sci J 2008;27:7–19.
   PubMed Web of Science ®Google Scholar
• Ohno S, Ohno Y, Suzuki N, Soma G, Inoue M. High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer. Anticancer Res 2009;29:809–815.
   PubMed Web of Science ®Google Scholar
• Du J, Martin SM, Levine M, Wagner BA, Buettner GR, Wang SH, Taghiyev AF, Du C, Knudson CM, Cullen JJ. Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res 2010;16:509–520.
   PubMed Web of Science ®Google Scholar
• Monti DA, Mitchell E, Bazzan AJ, Littman S, Zabrecky G, Yeo CJ, Pillai MV, Newberg AB, Deshmukh S, Levine M. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One 2012;7:e29794.
   PubMed Web of Science ®Google Scholar
• Shatzer AN, Espey MG, Chavez M, Tu H, Levine M, Cohen JI. Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo. Leuk Lymphoma 2013;54:1069–1078.
   PubMed Web of Science ®Google Scholar
• Pathi SS, Lei P, Sreevalsan S, Chadalapaka G, Jutooru I, Safe S. Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells. Nutr Cancer 2011;63:1133–1142.
   PubMed Web of Science ®Google Scholar
• Olney KE, Du J, van ‘t Erve TJ, Witmer JR, Sibenaller ZA, Wagner BA, Buettner GR, Cullen JJ. Inhibitors of hydroperoxide metabolism enhance ascorbate-induced cytotoxicity. Free Radic Res 2013;47:154–163.
   PubMed Web of Science ®Google Scholar
• Suh SY, Bae WK, Ahn HY, Choi SE, Jung GC, Yeom CH. Intravenous vitamin C administration reduces fatigue in office workers: A double-blind randomized controlled trial. Nutr J 2012;11:7. doi: 10.1186/1475-2891-11-7.
   PubMedGoogle Scholar
• Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda-Massari JR, Alexandrescu DT, Dasanu CA, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med 2011;9:25. doi: 10.1186/1479-5876-9-25.
   PubMedGoogle Scholar